文献速递头颈部肿瘤放疗姑息放疗与转移瘤

头颈部癌症放射治疗患者的颈动脉狭窄与缺血性卒中:一项批判性综述

Carotid Artery Stenosis and Ischemic Stroke in Patients With Head and Neck Cancer Treated With Radiation Therapy: A Critical Review.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2024-04-05

本综述总结头颈部癌症(HNC)放疗后颈动脉狭窄(CAS)与缺血性卒中的文献,以指导评估、筛查和管理策略。荟萃分析显示约25%患者发生CAS>50%,10年卒中累积发生率5.7%–12.5%;心血管风险预测工具(Qstroke、QRISK-2、Framingham)预测缺血性卒中表现不佳;5部主要HNC生存指南中仅3部承认放疗为危险因素,仅1部(美国头颈学会)给出CAS筛查具体推荐;普通人群中仅1部心血管指南(血管外科学会)讨论放疗为CAS危险因素。

要点

  • HNC放疗患者CAS>50%发生率约25%,10年卒中累积发生率5.7%–12.5%。
  • Qstroke、QRISK-2和Framingham风险评分对HNC放疗患者缺血性卒中预测表现不佳。
  • 5部主要HNC生存指南中仅3部承认放疗为CAS或IS危险因素,仅美国头颈学会给出CAS筛查具体推荐。

核心结论

  • HNC放疗患者CAS和IS风险升高,风险预测存在挑战;虽缺乏证据作出明确推荐,HNC生存建议应确保幸存者和初级保健提供者知晓这些风险及心血管危险因素评估与管理的重要性。
  • 未来研究需完善HNC患者风险预测模型,并确定最可能从靶向筛查和早期预防策略中获益的人群。

研究设计与样本

  • 批判性综述,总结HNC放疗患者CAS和IS的文献,以指导评估、筛查和管理策略。

主要发现

  • 已发表荟萃分析显示CAS>50%发生于约25%的HNC放疗患者。
  • 既往研究提示10年卒中累积发生率在5.7%至12.5%之间。
  • Qstroke、QRISK-2和Framingham风险评分等心血管疾病风险预测工具对接受放疗的HNC患者缺血性卒中预测表现不佳。
  • duplex超声是评估CAS最常用的影像 modality,但对无症状个体筛查的效用仍存争议。
  • 5部主要HNC生存指南中仅3部承认放疗为CAS或IS的危险因素,仅1部(美国头颈学会)对CAS筛查作出具体推荐;普通人群中仅1部心血管疾病指南(血管外科学会)讨论放疗为CAS危险因素。

关键数值与推荐

  • CAS>50%发生于约25%的HNC放疗患者(据已发表荟萃分析)。
  • 10年卒中累积发生率5.7%至12.5%(据既往研究)。

临床怎么用

  • 参与HNC放疗患者照护的临床医生应知晓CAS和IS风险升高及风险预测的挑战。
  • HNC生存建议应确保幸存者和初级保健提供者知晓这些风险及心血管危险因素评估与管理的重要性(作者认为,因缺乏证据作出明确推荐)。

局限性

  • 缺乏证据以作出明确推荐。
  • 未来研究需完善HNC患者风险预测模型并确定最可能从靶向筛查和早期预防策略中获益的人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The purpose of this review is to summarize the literature on carotid artery stenosis (CAS) and ischemic stroke (IS) in patients with head and neck cancer (HNC) treated with radiation therapy (RT) to guide assessment, screening, and management strategies. Patients treated with RT for HNC are at an elevated risk of developing CAS, with published meta-analyses demonstrating that CAS >50% occurs in approximately 25% of patients. Previous research suggests a 10-year cumulative incidence of stroke between 5.7% and 12.5%. Cardiovascular disease (CVD) risk prediction tools such as Qstroke, QRISK-2, and Framingham risk score perform poorly for predicting IS for patients with HNC who received RT. Duplex ultrasound is the most common imaging modality to assess CAS, but controversy remains as to the utility of screening asymptomatic individuals. Only 3 of the 5 major HNC survivorship guidelines acknowledge RT as a risk factor for CAS or IS, while only 1 makes a specific recommendation on screening for CAS (American Head and Neck Society). Within the general population, only 1 CVD guideline discusses RT as a risk factor for CAS (Society for Vascular Surgery). Clinicians involved in the care of patients with HNC treated with RT should be aware of the increased risk of CAS and IS and the challenges in risk prediction. Although there is a lack of evidence to make firm recommendations, HNC survivorship recommendations should ensure HNC survivors and primary care providers are informed of these risks and the importance of assessment and management of CVD risk factors. Future studies are required to refine risk prediction models in patients with HNC and to determine those most likely to benefit from targeted screening and initiation of early preventative strategies.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Smith J, Margalit D, Golledge J, et al. Carotid Artery Stenosis and Ischemic Stroke in Patients With Head and Neck Cancer Treated With Radiation Therapy: A Critical Review. Int J Radiat Oncol Biol Phys. 2024. PMID: 38583496. doi:10.1016/j.ijrobp.2024.03.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。